Editorial: Upper GI bleeding-associated mortality: Challenges to improving a resistant outcome

American Journal of Gastroenterology

Volumn 105, Issue 1, 2010, Pages 90-92

  Lanas, Angel ^a  

^a UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER MORTALITY; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; HIGH RISK PATIENT; HUMAN; LUNG DISEASE; MORTALITY; MULTIPLE ORGAN FAILURE; OUTCOMES RESEARCH; PEPTIC ULCER; PEPTIC ULCER BLEEDING; PRIORITY JOURNAL; REVIEW; RISK FACTOR; UPPER GASTROINTESTINAL BLEEDING;

AGED; CAUSE OF DEATH; COMORBIDITY; FEMALE; GASTROSCOPY; HONG KONG; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PEPTIC ULCER HEMORRHAGE; RISK FACTORS; SEX FACTORS; WORLD HEALTH;

EID: 73849149849     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.517     Document Type: Review

References (19)

1. Zhao Y, Encinosa W. Hospitalizations for gastrointestinal bleeding 1998 and 2006. HCUP Statistical Brief #65. December 2008.
2. Agency for Healthcare Research and Quality. Rockville, MD http://www.hcup-us.ahr.gov/reports/ statbriefs/sb65.pdf.
3. Lanas A, García-Rodríguez L A, Polo-Tomás M et al. Time trends an d impact oflupper and lower gastrointestinal bleeding and perforation in clinical practice. Am J Gastroenterol 2009;104:1633-1641
4. Pérez-Aisa M A, Del Pino D, Siles M et al. Clinical trends in ulcer diagnosis in a population with high prevalence of Helicobacter pylori infection. Aliment Pharmacol Ter 2005;21:65-67
5. Sonnenberg A. Time trends oflulcer mortality in Europe. Gastro enterology 2007;132:2320-2327
6. Chan F K, Abraham N S, Scheiman JM et al. First International Working Party On Gastrointestinal And Cardiovascular Effects Of Nonsteroidal Anti-Inflammatory Drugs And Anti-Platelet Agents. Management of patients on nonsteroidal anti-inflammatory drugs: a clinical practice recommendation from the First International Working Party on Gastrointestinal and Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs and Anti-platelet Agents. Am J Gastroenterol 2008;103:2908-2918
7. Ramsoekh D, van Leerdam M E, Rauws E A. et al. Outcome of pepticulcer bleeding, nonsteroidal anti-inflammatory drug use, and Helicobacter pylori infection. Clin Gastroenterol Hepatol 2005; 3: 859-864
8. Wu C Y, Wu C H, Wu M S et al. A nation wide population-based cohort study shows reduced hospitalization for peptic ulcer disease associated with H. pylori eradication and proton pump inhibitor use. Clin Gastroenterol Hepatol 2009;7:427-431
9. Lanas A, Perez-Aisa M A, Feu F. et al. A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with nonsteroidal antiinfammatory drug use. Am J Gastroenterol 2005;100:1685-1693
10. Leontiadis G I, Howden C W. The role of proton pump inhibitors in the management oflupper gastrointestinal bleeding. Gastroenterol Clin North Am 2009;38:199-213.
11. Barkun A N, Martel M, Toubouti Y et al. Endoscopic hemostasis in peptic ulcer bleeding for patients with high-risk lesions: a series of meta-analyses. Gastrointest Endosc 2009;69:786-799
12. Sadic J, Borgström A, Manjer J et al. Bleeding pepticulcer \-time trends in incidence, treatment and mortality in Sweden. Aliment Pharmacol Ter 2009;6 (E-pub ahead of print).
13. Sung JJ, Barkun A, Kuipers E J, Peptic Ulcer Bleed Study Group et al. In tra-venous esomeprazole for prevention of recurrent peptic ulcer bleeding: a randomized trial. Ann Intern Med 2009; 150: 455-464
14. van Rensburg C, Barkun A N, Racz I et al. Clinical trial: intravenous pantoprazole vs. ranitidine for the prevention of peptic ulcer rebleeding: a multicentre, multinational, randomized trial. Aliment Pharmacol Ter 2009;29:497-507.
15. Barkun A, Sabbah S, Enns R et al. The Canadian Registry on Nonvariceal Upper Gastrointestinal Bleeding and Endoscopy (RUGBE): Endoscopic hemostasis and proton pump inhibition are associated with improved outcomes in a real-life setting. Am J Gastroenterol 2004;99:1238-1246
16. Vergara M, Calvet X, Gisbert JP. Epinephrine injection versus epinephrine injection and a second endoscopic method in high risk bleeding ulcers. Cochrane Database Syst Rev 2007;18:CD005584.
17. Sung J J, Tsoi K, Ma Thet al. Causes of mortality in patients with peptic ulcer bleeding: a prospective cohort study of 10,428 cases. Am J Gastroenterol 2010;105:84-89 (this issue).
18. Klebl F H, Bregenzer N, Schöfer L et al. Comparison of in patient and outpatient upper gastrointestinal haemorrhage. Int J Colorectal Dis 2005;20:368-375
19. Sung J J, Lau J Y, Ching J Y et al. Can aspirin be reintroduced with proton pump inhibitor infusion affer endoscopic hemostasis? A double blinded randomized controlled trial. Gastroenterology 2006;130 (Suppl 2): A-44.